Health Condition 1: F411- Generalized anxiety disorder Health Condition 2: F411- Generalized anxiety disorder
Conditions
Interventions
Intervention1: Homoeopathic Medicine: Individualized Homoeopathic medicine with appropriate potency selected by detail case taking based on homoeopathic principal and GMP certified company medicine wi
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: (1) Diagnosed as generalized anxiety disorder as per DSM V diagnostic criteria. (2) Patients in age group 18 to 60 years at a time of enrollment (3) Patients of both the sexes taken. (4) Minimum duration of treatment should be at least 6 months. (5) Generalized Anxiety Disorder 7 scale score ranging from 5 to 14. (6) Patients are willing to only Homoeopathic treatment for the GAD. (7) Able to provide written informed consent and able to understand study procedures and questionnaires in the study language. (8) No psychotropic medication for at least 4 weeks prior to baseline
Exclusion criteria
Exclusion criteria: (1) Current primary psychiatry diagnosis other than GAD that requires immediate alternative management (Eg. Psychotic disorders, bipolar disorder) (2) Cases diagnosed with severe major depression disorder with active suicidal ideation or intent (assessed clinically); any participants with imminent suicidal risk should be referred to urgent care and excluded. (3) Current substance use disorder (moderate severe) or active dependence on alcohol or illicit drugs in the past 3 months. (4) Use of new psychotropic medication, psychotherapy, or other formal anxiety treatment initiated within 4 weeks prior to baseline (5) Patient having uncontrolled Thyroid disease or severe cardiac diseases, diagnosed case of cancer. (6) Pregnant or breastfeeding women during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To measure the pre- and post- changes in anxiety levels and intensity such as nervousness on edge, being able to control worry, worrying about different things, trouble relaxing, restlessness, irritability, anticipation assessed by Generalized Anxiety Disorder 7 (GAD 7) scale which will be assessed before and after six months of the Homoeopathic treatment among the adults suffering from Generalized Anxiety Disorders.Timepoint: 1.To measure the pre- and post- changes in anxiety levels and intensity, assessed by Generalized Anxiety Disorder 7 (GAD 7) scale will be assessed before and six months after the Homoeopathic treatment among the adults suffering from Generalized Anxiety Disorders. GAD 7scale is applied two times firstly before homoeopathic intervention and secondly after six months of homoeopathic treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To study the therapeutic indications of the commonly prescribed and clinically relevant individualized homoeopathic medicines effective for the treatment of GAD among adults. 2. To describe the distinguishing Materia Medica features that aid in differentiating among the most frequently indicated homoeopathic medicines prescribed for GAD. Timepoint: 6 months to 12 months | — |
Countries
India
Contacts
Public ContactDr Pushkar Ramesh Mahajan
DKMM Homoeopathic Medical College and Hospital
Outcome results
None listed